ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 552 filers reported holding ASTRAZENECA PLC in Q4 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,935,000 | +33.9% | 148,922 | +33.9% | 0.05% | +53.1% |
| Q2 2021 | $6,673,000 | -25.0% | 111,211 | -37.6% | 0.03% | -27.3% |
| Q1 2021 | $8,901,000 | -0.8% | 178,130 | -0.3% | 0.04% | -8.3% |
| Q4 2020 | $8,971,000 | +4.1% | 178,755 | +14.3% | 0.05% | -5.9% |
| Q3 2020 | $8,620,000 | -10.8% | 156,423 | -14.4% | 0.05% | -16.4% |
| Q2 2020 | $9,668,000 | -8.6% | 182,720 | -23.0% | 0.06% | -21.8% |
| Q1 2020 | $10,572,000 | +13.9% | 237,429 | +28.0% | 0.08% | +52.9% |
| Q4 2019 | $9,279,000 | +6.1% | 185,535 | -3.9% | 0.05% | +4.1% |
| Q3 2019 | $8,745,000 | +22.6% | 193,158 | +11.0% | 0.05% | +25.6% |
| Q2 2019 | $7,135,000 | -21.2% | 174,074 | -17.4% | 0.04% | -23.5% |
| Q1 2019 | $9,053,000 | +72.5% | 210,627 | +51.6% | 0.05% | +54.5% |
| Q4 2018 | $5,247,000 | +68.9% | 138,903 | +77.6% | 0.03% | +94.1% |
| Q3 2018 | $3,107,000 | +374.4% | 78,222 | +319.4% | 0.02% | +325.0% |
| Q2 2018 | $655,000 | 0.0% | 18,649 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $655,000 | -5.6% | 18,649 | -6.8% | 0.00% | 0.0% |
| Q4 2017 | $694,000 | -4.7% | 20,014 | -6.8% | 0.00% | 0.0% |
| Q3 2017 | $728,000 | -0.7% | 21,478 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $733,000 | -4.2% | 21,478 | -12.5% | 0.00% | -20.0% |
| Q1 2017 | $765,000 | +13.8% | 24,548 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $672,000 | -41.8% | 24,548 | -29.7% | 0.00% | -42.9% |
| Q3 2016 | $1,154,000 | -78.3% | 34,933 | -80.4% | 0.01% | -80.0% |
| Q2 2016 | $5,311,000 | +155.5% | 177,926 | +142.4% | 0.04% | +150.0% |
| Q1 2016 | $2,079,000 | +151.1% | 73,409 | +205.9% | 0.01% | +133.3% |
| Q4 2015 | $828,000 | +10.3% | 24,000 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $751,000 | -85.5% | 24,000 | -67.3% | 0.01% | -84.4% |
| Q4 2014 | $5,186,000 | -1.7% | 73,354 | 0.0% | 0.03% | -3.0% |
| Q3 2014 | $5,277,000 | -15.1% | 73,354 | -12.6% | 0.03% | -15.4% |
| Q2 2014 | $6,217,000 | -22.7% | 83,889 | -32.0% | 0.04% | -27.8% |
| Q1 2014 | $8,047,000 | -24.7% | 123,420 | -31.2% | 0.05% | -28.0% |
| Q4 2013 | $10,680,000 | -25.9% | 179,484 | -35.5% | 0.08% | -32.4% |
| Q3 2013 | $14,407,000 | -21.6% | 278,281 | -27.3% | 0.11% | -22.4% |
| Q2 2013 | $18,367,000 | – | 382,741 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |